These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8700790)
1. Insights into mechanisms of cisplatin resistance and potential for its clinical reversal. Gosland M; Lum B; Schimmelpfennig J; Baker J; Doukas M Pharmacotherapy; 1996; 16(1):16-39. PubMed ID: 8700790 [TBL] [Abstract][Full Text] [Related]
3. Resistance to cisplatin. Akiyama S; Chen ZS; Sumizawa T; Furukawa T Anticancer Drug Des; 1999 Apr; 14(2):143-51. PubMed ID: 10405641 [TBL] [Abstract][Full Text] [Related]
4. [Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin]. Rixe O Bull Cancer; 2000 Aug; 87 Spec No():7-15. PubMed ID: 11082717 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities. Byun SS; Kim SW; Choi H; Lee C; Lee E BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938 [TBL] [Abstract][Full Text] [Related]
6. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin. Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583 [TBL] [Abstract][Full Text] [Related]
7. Cisplatin and platinum drugs at the molecular level. (Review). Boulikas T; Vougiouka M Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679 [TBL] [Abstract][Full Text] [Related]
8. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810 [TBL] [Abstract][Full Text] [Related]
9. Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors. Saga Y; Hashimoto H; Yachiku S; Iwata T; Tokumitsu M Int J Urol; 2004 Jun; 11(6):407-15. PubMed ID: 15157211 [TBL] [Abstract][Full Text] [Related]
10. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells. Zhang T; Guan M; Jin HY; Lu Y Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151 [TBL] [Abstract][Full Text] [Related]
12. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer. Macleod K; Mullen P; Sewell J; Rabiasz G; Lawrie S; Miller E; Smyth JF; Langdon SP Cancer Res; 2005 Aug; 65(15):6789-800. PubMed ID: 16061661 [TBL] [Abstract][Full Text] [Related]
13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Stordal BK; Davey MW; Davey RA Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310 [TBL] [Abstract][Full Text] [Related]
15. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells. Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617 [TBL] [Abstract][Full Text] [Related]
17. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system. Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype. Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542 [TBL] [Abstract][Full Text] [Related]
19. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. O'Neill CF; Koberle B; Masters JR; Kelland LR Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725 [TBL] [Abstract][Full Text] [Related]
20. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]